Approval · Notice of Compliance 7076 · 2005
HYPERHEP B S/D: Notice of Compliance 7076
Issued June 8, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7076
- Date
- June 8, 2005
- Company
- Talecris Biotherapeutics, Inc.Clayton, North Carolina, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYPERHEP B S/D | 02230738 | Cancelled Post Market |
Medicinal ingredients
- HEPATITIS B IMMUNOGLOBULIN (HUMAN) 217 UNIT per ML